🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DNT
$DNTH
🔒 US EquitiesDianthus Therapeutics Inc
AVG HISTORICAL GAP
+2.58%
MAX GAP RECORD
+21.01%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DNTH
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DNTH
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
+1.53%
|
| May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN) |
+1.37%
|
| Mar 09, 2026 Earnings Release 2026-03-09 (BEFORE OPEN) |
+21.01%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE) |
+0.36%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
-0.78%
|
| May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE) |
-2.59%
|
| Mar 11, 2025 Earnings Release 2025-03-11 (AFTER CLOSE) |
-6.54%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE) |
+7.86%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.2%
Bullish Gaps (5)
Bearish Gaps (2)
Neutral / Flat (5)
📖 Intelligence Summary
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗